Cargando…

The preventive effect of low-dose aspirin in a PPAR-γ antagonist treated mouse model of preeclampsia

BACKGROUND: Preeclampsia (PE) is one of the leading causes of maternal and perinatal mortality and morbidity. Low-dose aspirin (LDA) is the most widely used drug to prevent PE, but the recommended dose of LDA varies according to different guidelines. Peroxisome proliferator-activated receptor (PPAR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yongbing, Zhu, Yuchun, Sun, Yu, Yang, Huixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338524/ https://www.ncbi.nlm.nih.gov/pubmed/35906540 http://dx.doi.org/10.1186/s12884-022-04901-x

Ejemplares similares

Preventive effect of aspirin on preeclampsia in high‐risk pregnant women with stage 1 hypertension
por: Huai, Jing, et al.
Publicado: (2021)

Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial
por: Lin, Li, et al.
Publicado: (2018)

The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
por: Walsh, Scott W., et al.
Publicado: (2021)

Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017)

Low-dose aspirin in the prevention of pre-eclampsia in China: postpartum hemorrhage in subgroups of women according to their characteristics and potential bleeding risk
por: Chen, Jiahui, et al.
Publicado: (2023)

Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
por: Zhou, Qiongjie, et al.
Publicado: (2023)

Risk Threshold for Starting Low Dose Aspirin in Pregnancy to Prevent Preeclampsia: An Opportunity at a Low Cost
por: Bartsch, Emily, et al.
Publicado: (2015)

286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia
por: Rottenstreich, Amihai, et al.
Publicado: (2023)

Aspirin for Prevention of Preeclampsia in Lupus Pregnancy
por: Schramm, Amelie M., et al.
Publicado: (2014)

353 MFM Provider Adherence to USPSTF Low Dose Aspirin Guidelines for Preeclampsia Prevention in Nulliparous Patients
por: Myers, Sabrena O., et al.
Publicado: (2022)

Preeclampsia and aspirin
por: Ahn, Tae Gyu, et al.
Publicado: (2023)

C1431T Variant of PPARγ Is Associated with Preeclampsia in Pregnant Women
por: Liu, Fulin, et al.
Publicado: (2021)

Missed opportunities in aspirin prescribing for preeclampsia prevention
por: Singh, Noreen, et al.
Publicado: (2023)

Effect of Low-Dose Aspirin in Preventing Early-Onset Preeclampsia in the Taiwanese Population—A Retrospective Cohort Study
por: Law, Kim-Seng, et al.
Publicado: (2021)

Clinical efficacy of low-dose aspirin combined with calcium in preventing preeclampsia: A systematic review and meta-analysis
por: Chen, Wen-Yue, et al.
Publicado: (2023)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
por: Tsukahara, Tamotsu
Publicado: (2012)

Identification of Bexarotene as a PPARγ Antagonist with HDX
por: Marciano, David P., et al.
Publicado: (2015)

Low-dose aspirin might alleviate the symptoms of preeclampsia by increasing the expression of antioxidative enzymes
por: Xiong, Wen, et al.
Publicado: (2021)

The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia
por: Grimaldi, Brooke, et al.
Publicado: (2022)

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
por: Zheng, Li, et al.
Publicado: (2022)

Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis
por: Cui, Yuechong, et al.
Publicado: (2018)

Identification of an irreversible PPARγ antagonist with potent anticancer activity
por: Peng, Youyi, et al.
Publicado: (2020)

ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia
por: Liu, Lei, et al.
Publicado: (2017)

Low-Dose Aspirin Prevents Kidney Damage in LPS-Induced Preeclampsia by Inhibiting the WNT5A and NF-κB Signaling Pathways
por: Li, Guanlin, et al.
Publicado: (2021)

Low‐dose‐aspirin usage among women with an increased preeclampsia risk: A prospective cohort study
por: van Montfort, Pim, et al.
Publicado: (2020)

The role of low-dose aspirin in the prevention of pre-eclampsia
por: Akhigbe, R. E.
Publicado: (2014)

Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
por: Malaviya, Abhita, et al.
Publicado: (2014)

BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model
por: Yuan, Na, et al.
Publicado: (2018)

Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial
por: Diguisto, Caroline, et al.
Publicado: (2022)

Aspirin and Preeclampsia Prevention in Patients With Abnormal Uterine Artery Blood Flow
por: Talari, Hamidreza, et al.
Publicado: (2014)

Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis
por: Mkhize, P.Z., et al.
Publicado: (2021)

Aspirin for the prevention of preeclampsia: A systematic review and meta-analysis of randomized controlled studies
por: Wang, Yixiao, et al.
Publicado: (2022)

Molecular docking analysis of PPARγ antagonists for obesity associated diabetes management
por: Ahmad, Aftab, et al.
Publicado: (2023)

Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis
por: Rohwer, Nadine, et al.
Publicado: (2020)

Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis
por: Van Doorn, Rachel, et al.
Publicado: (2021)

Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial
por: Souza, E.V., et al.
Publicado: (2014)

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review
por: Wu, Chunfeng, et al.
Publicado: (2021)

Pparγ2 Is a Key Driver of Longevity in the Mouse
por: Argmann, Carmen, et al.
Publicado: (2009)

Low dose aspirin and pregnancy: how important is aspirin resistance?
por: Navaratnam, K, et al.
Publicado: (2016)

Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats
por: Shvartsur, Rachel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cimi8iasuc0336l738r1gthe6q